Merck advances two partnerships with biotech Canucks

Ryan McBride As Merck ($ MRK) works on rebooting R&D, the drug giant has rewarded a pair of its biotech partners in Canada for their progress with separate preclinical programs. ...

Merck kept mum on Fosamax’s fracture risks, trial lawyer says

Tracy Staton Image courtesy of NIH Did Merck know about increased fracture risk in Fosamax patients years before the osteoporosis treatment hit the market? A plaintiff’s ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS